EC Neurology

Short Communication Volume 17 Issue 1 - 2025

Shogaols as Epigenetic Compounds

Vladimir Badmaev*

American Medical Holdings, Inc. Staten Island, NY, USA

*Corresponding Author: Vladimir Badmaev, American Medical Holdings, Inc. Staten Island, NY, USA.
Received: November 25, 2024; Published: December 17, 2024



The dramatic difference in human quality of life, health, and lifespan may depend not on the pool of inherited genes but their relative expression. Specific genes turned on to express related functions with others suppressed under the control mechanisms grouped under the term "epigenetics." The polyphenolic compound 6-Shogaol demonstrated significant potential in improving the clinical condition of MDS patients and is discussed as a possible epigenetic compound.

 Keywords: Shogaols; 6-Shogaol; MDS; BOS; ASXL 1 Gene; Epigenetics

Vladimir Badmaev. “Shogaols as Epigenetic Compounds”. EC Neurology  17.1 (2025): 01-02.